Evidence map›Paper›PMID 39235824›Full record

ArticleEpileptic disorders : international epilepsy journal with videotape2024

Primary treatment gap among adults with epilepsy: A cross-sectional analysis.

Housam Soboh, Jacques Theitler, Revital Gandelman-Marton

Abstract read
In one paragraph

Article in Epileptic disorders : international epilepsy journal with videotape, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Primary treatment gap among adults with epilepsy: A cross-sectional analysis.Epileptic disorders : international epilepsy journal with videotape · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Housam SobohNeurology Department, Meir Medical Center, Kfar Saba, Israel.
Jacques TheitlerNeurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel.
Revital Gandelman-MartonNeurology Department, Shamir-Assaf Harofeh Medical Center, Zerifin, Israel.ORCID https://orcid.org/0000-0001-5415-7482

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDespite recommendations to initiate antiseizure medication treatment once the diagnosis of epilepsy is confirmed, a certain proportion of patients with epilepsy who should receive antiseizure medication treatment remain untreated. We aimed to evaluate the rate of and the reasons for the treatment gap in patients with epilepsy who were referred to their first visit in our epilepsy clinic.

methodsWe retrospectively reviewed the computerized database and the medical records of all the patients with epilepsy who had their first visit in our outpatient epilepsy clinic during a 10-year period (2012-2021).

resultsForty-nine (6.5%) of 746 patients with epilepsy were not treated with antiseizure medications: 27 (3.6%) were nonadherent to treatment, 12 (1.6%) patients were not definitively diagnosed with epilepsy prior to their first epilepsy clinic visit, and in 10 (1.3%) patients antiseizure medication treatment was not recommended. Untreated patients had shorter epilepsy duration compared to patients treated with antiseizure medications (p = .003). At last follow-up, 77% of the untreated patients at first visit were receiving antiseizure medications compared to 97% of the initially treated group, and fewer were receiving antiseizure medication polytherapy (p = .0001). SIGNIFICANCE: Although the rate of treatment gap was relatively low, we believe that it should be further reduced. Efforts may focus on addressing individual causes of nonadherence to antiseizure medication treatment and on promoting knowledge of diagnosis and treatment of epilepsy among healthcare professionals.

Indexed as

AnticonvulsantsEpilepsyAdultAgedCross-Sectional StudiesDrug MonitoringFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultAnticonvulsantsantiseizure medicationsepilepsytreatment gap

Identifiers

PMID39235824
PMCPMC11651376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.